AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+3.46%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$343M
AUM Growth
+$343M
(-13%)
Cap. Flow
-$57.3M
Cap. Flow
% of AUM
-16.69%
Top 10 Holdings %
Top 10 Hldgs %
78.35%
Holding
286
New
92
Increased
42
Reduced
67
Closed
66
Top Buys
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$1.83M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$1.27M |
| 3 |
GXO Logistics
GXO
|
$1.27M |
| 4 |
Intuitive Surgical
ISRG
|
$1.17M |
| 5 |
MP Materials
MP
|
$1.14M |
Top Sells
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$30.3M |
| 2 |
iShares MBS ETF
MBB
|
$29.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$1.86M |
| 4 |
Azenta
AZTA
|
$1.54M |
| 5 |
Synopsys
SNPS
|
$1.5M |
Sector Composition
| 1 | Real Estate | 24.12% |
| 2 | Healthcare | 12.62% |
| 3 | Technology | 1.66% |
| 4 | Financials | 1.65% |
| 5 | Industrials | 1.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Exelixis
EXEL
$10.1B
| $695K | 0.2% |
38,000
+15,000
| +65% | +$274K |
|
52
Enact Holdings
ACT
$5.55B
| $686K | 0.2% |
+33,168
| New | +$686K |
|
|
NYMT
53
New York Mortgage Trust
NYMT
$652M
| $682K | 0.2% |
183,212
+25,000
| +16% | +$93.1K |
|
54
Celldex Therapeutics
CLDX
$1.47B
| $657K | 0.19% |
17,000
| – | – |
|
55
Welltower
WELL
$113B
| $643K | 0.19% |
7,500
+5,000
| +200% | +$429K |
|
56
iShares 7-10 Year Treasury Bond ETF
IEF
$35.7B
| $640K | 0.19% |
5,564
+5,284
| +1,887% | +$608K |
|
57
Merck
MRK
$210B
| $613K | 0.18% |
8,000
-1,750
| -18% | -$134K |
|
|
RWT
58
Redwood Trust
RWT
$791M
| $596K | 0.17% |
45,148
| – | – |
|
59
ClearPoint Neuro
CLPT
$298M
| $561K | 0.16% |
50,000
-7,500
| -13% | -$84.2K |
|
60
Sarepta Therapeutics
SRPT
$1.78B
| $540K | 0.16% |
6,000
-3,000
| -33% | -$270K |
|
61
ALX Oncology
ALXO
$62.7M
| $527K | 0.15% |
+24,500
| New | +$527K |
|
|
AMRN
62
Amarin Corp
AMRN
$311M
| $506K | 0.15% |
+150,000
| New | +$506K |
|
63
Fulcrum Therapeutics
FULC
$351M
| $504K | 0.15% |
+28,500
| New | +$504K |
|
64
MGIC Investment
MTG
$6.42B
| $487K | 0.14% |
33,775
| – | – |
|
|
SAGE
65
DELISTED
Sage Therapeutics
SAGE
| $468K | 0.14% |
11,000
+5,000
| +83% | +$213K |
|
66
iShares Russell 1000 Value ETF
IWD
$63.5B
| $423K | 0.12% |
+2,518
| New | +$423K |
|
67
Invesco S&P 500 Pure Value ETF
RPV
$1.36B
| $423K | 0.12% |
+5,237
| New | +$423K |
|
|
FUSN
68
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $417K | 0.12% |
100,000
+28,500
| +40% | +$119K |
|
69
Castle Biosciences
CSTL
$696M
| $407K | 0.12% |
+9,500
| New | +$407K |
|
70
iShares Russell 1000 Growth ETF
IWF
$116B
| $407K | 0.12% |
+1,332
| New | +$407K |
|
71
Invesco S&P 500 Pure Growth ETF
RPG
$1.72B
| $396K | 0.12% |
+1,880
| New | +$396K |
|
|
CMPS
72
Compass Pathways
CMPS
$424M
| $387K | 0.11% |
+17,500
| New | +$387K |
|
73
Iovance Biotherapeutics
IOVA
$807M
| $382K | 0.11% |
20,000
-10,500
| -34% | -$201K |
|
74
Agios Pharmaceuticals
AGIO
$2.19B
| $378K | 0.11% |
+11,500
| New | +$378K |
|
|
GTH
75
DELISTED
Genetron Holdings Limited ADS
GTH
| $375K | 0.11% |
+61,500
| New | +$375K |
|